NCT02314689 A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02285088 A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02273310 Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease Status COMPLETED Phase NA
NCT02261480 A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease Status COMPLETED Phase N/A
NCT02227472 Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease Status COMPLETED Phase N/A
NCT02225132 Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02222246 Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease Status COMPLETED Phase PHASE4
NCT02200510 Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease Status COMPLETED Phase NA
NCT02197845 Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators Status COMPLETED Phase NA
NCT02193191 Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02187445 Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial Status COMPLETED Phase PHASE1
NCT02179359 Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Status TERMINATED Phase NA
NCT02151526 A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2